TREA

97602817 - RAPID

Follow

Information

  • Trademark
  • 97602817
  • Serial Number
    97602817
  • Filing Date
    September 22, 2022
    2 years ago
  • Transaction Date
    June 15, 2023
    a year ago
  • Status Date
    June 15, 2023
    a year ago
  • Location Date
    April 10, 2023
    a year ago
  • Status Code
    601
  • Current Location
    TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    TATE-NAGHI, JACQUELINE
  • Attorney Docket Number
    4040.0017T
    Attorney Name
    Leesa N. Weiss
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
RAPID
Case File Statements
  • GS0401: custom manufacture of bacteriophage therapeutics
  • DM0000: The mark consists of the word "RAPID" to the right of a hexagon design made up of seven individual hexagons and lines connecting all but one of the seven hexagons.
  • GS0091: computer software system for identifying precision therapy for treatment of bacterial infections
  • GS0051: human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising reagents for testing bacteria sensitivity
  • GS0441: medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of a person; microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto; medical testing and diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
  • GS0421: research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals; clinical and medical laboratory testing services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and therapeutics; non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; microbiological laboratory testing of bacteria for research purposes and technical consultation thereto; scientific and medical research, in particular, design and development of diagnostic assays
Case File Event Statements
  • 6/15/2023 - a year ago
    15 - ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Type: MAB1
  • 6/15/2023 - a year ago
    14 - ABANDONMENT - EXPRESS MAILED Type: ABN1
  • 6/14/2023 - a year ago
    13 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 4/4/2023 - a year ago
    12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/4/2023 - a year ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/4/2023 - a year ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/4/2023 - a year ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/4/2023 - a year ago
    8 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/15/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/15/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/15/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/6/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/11/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/9/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/26/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP